文献速递妇产影像腹部MRPETCT

子宫颈癌与子宫内膜癌的扩散加权MRI及18氟脱氧葡萄糖PET/CT定量成像

Quantitative imaging of uterine cancers with diffusion-weighted MRI and 18-fluorodeoxyglucose PET/CT.
PubMed 文献 · Abdom Radiol (NY) · 2021-07-23

本文综述了扩散加权MRI、PET/CT及混合PET/MRI在子宫颈癌和子宫内膜癌评估中的定量成像作用:DWI可得ADC用于治疗前后评估,PET/CT的SUV用于分期,混合PET/MRI则结合软组织对比与分子成像。

要点

  • DWI所得ADC可用于子宫肿瘤治疗前及治疗后的评估。
  • PET/CT测量的肿瘤SUV是子宫恶性肿瘤分期的有用指标。
  • 混合PET/MRI结合MRI软组织对比与PET分子成像能力,为新兴模态。

核心结论

  • 定量成像(DWI的ADC、PET/CT的SUV及混合PET/MRI)可在解剖和定性描述之外进一步表征子宫原发肿瘤,在子宫颈癌和子宫内膜癌评估中具有当前和潜在作用。

研究设计与样本

  • 综述,概述DWI、PET/CT和混合PET/MRI等定量成像模态在子宫颈癌和子宫内膜癌评估中的作用;原文未报告检索范围与纳入文献。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Imaging plays an important role in the diagnosis and treatment of women with uterine cervical and endometrial cancers. Quantitative imaging, through MRI, PET/CT, and hybrid PET/MRI, allows for characterization of primary tumors beyond anatomic and qualitative descriptors. MRI diffusion-weighted imaging (DWI) yields an apparent diffusion coefficient (ADC), which can be applied in both the pre-and post-treatment assessment of uterine tumors. PET/CT assesses metabolic activity, and measurement of tumor standardized uptake value (SUV) is a useful metric in the staging of uterine malignancies. Hybrid PET/MRI is an emerging modality that combines the soft tissue contrast of MRI with the molecular imaging capability of PET. This review provides an overview of these quantitative imaging modalities, and their current and potential roles in the assessment of uterine cervical and cancer.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Sertic M, Kilcoyne A, Catalano OA, et al. Quantitative imaging of uterine cancers with diffusion-weighted MRI and 18-fluorodeoxyglucose PET/CT. Abdom Radiol (NY). 2021. PMID: 34302185. doi:10.1007/s00261-021-03218-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。